Product Information
SOLU-CORTEF 100 MG VIAL is a brand product labeled by Pharmacia & Upjohn Company LLC, priced at $25.7267 per EA under NDC 00009082501. Its NADAC has been published 659 times since Feb 19, 2014.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AP.
Strength
100 mg/2mL
Manufacturer
Pharmacia & Upjohn Company LLCNDC
00009082501
Classification
Brand
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
10/1/2026
Active Ingredients
HYDROCORTISONE SODIUM SUCCINATEApproval Type
New Drug (NDA)
FDA Application
NDA009866FDA Approved
Before 1982
TE Code
AP
On Market Since
4/27/1955
Pharmacological Classes
Price Statistics
The NADAC for SOLU-CORTEF 100 MG VIAL has been published 659 times since Feb 19, 2014, and over the history we have for it it has risen 503.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $25.7267 per EA |
|---|---|
| All-time high | $25.7267 (Sep 30, 2026) |
| All-time low | $4.2660 (Feb 19, 2014) |
| 52-week high | $25.7267 |
| 52-week low | $18.1883 |
| Median price | $10.3186 |
| Average price | $11.0214 |
| Largest weekly change | +25.6% (Sep 30, 2026) |
| Weeks tracked | 659 |
| Tracking since | Feb 19, 2014 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Weekly brief
Featured in the latest weekly brief
This NDC appears in the current executive summary of the most important weekly NADAC moves.
Manufacturer
Pharmacia & Upjohn Company LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
hydrocortisone sodium succinate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SOLU-CORTEF 100 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for SOLU-CORTEF 100 MG VIAL, manufactured by Pharmacia & Upjohn Company LLC, is $25.7267 per EA (NDC 00009082501), effective Sep 30, 2026.
How has the price of SOLU-CORTEF 100 MG VIAL changed over time?
Over the history we have for it, the NADAC for SOLU-CORTEF 100 MG VIAL has risen 503.1%. It has been tracked across 659 weekly CMS publications since Feb 19, 2014.
What are the highest and lowest recorded NADAC prices for SOLU-CORTEF 100 MG VIAL?
Since Feb 19, 2014, the NADAC for SOLU-CORTEF 100 MG VIAL has ranged from a low of $4.2660 (Feb 19, 2014) to a high of $25.7267 (Sep 30, 2026), with a median of $10.3186 per EA.
Are there cheaper alternatives to SOLU-CORTEF 100 MG VIAL?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SOLU-CORTEF 100 MG ACT-O-VIAL, is $24.6832 per EA — about 4% below SOLU-CORTEF 100 MG VIAL.
Who manufactures SOLU-CORTEF 100 MG VIAL?
SOLU-CORTEF 100 MG VIAL (NDC 00009082501) is labeled by Pharmacia & Upjohn Company LLC, and CMS classifies it as a brand product.